Clinical Trials Browser

Leukemia, Myeloid, Acute × Valproic Acid × Clear all

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02124174 2021-04-26

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Phase 2 Unknown

50 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00414310 2019-05-21

Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Phase 2 Completed

153 enrolled 8 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00867672 2016-08-31

DECIDER

Phase 2 Completed

204 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00175812 2015-06-24

Differentiation Induction in Acute Myelogenous Leukemia

Phase 1/2 Completed

24 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00995332 2015-06-24

Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine

Phase 1/2 Completed

36 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01369368 2015-06-24

Treatment of Acute Leukemia Relapse After Allotransplantation

Phase 1/2 Unknown

20 enrolled

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT00079378 2013-09-30

Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 1 Completed

84 enrolled

LymphoidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT00382590 2012-08-07

Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients

Phase 2 Completed

11 enrolled 6 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00326170 2012-06-15

Phase II 5-Azacytidine Plus VPA Plus ATRA

Phase 2 Completed

34 enrolled 5 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Clinical Trials

HUVAMER

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

DECIDER

Differentiation Induction in Acute Myelogenous Leukemia

Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine

Treatment of Acute Leukemia Relapse After Allotransplantation

Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients

Phase II 5-Azacytidine Plus VPA Plus ATRA